Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials

Loxapine, a first-generation antipsychotic, delivered with a novel inhalation delivery device developed for the acute treatment of agitation in patients with schizophrenia or bipolar disorder was evaluated in subjects with asthma or chronic obstructive pulmonary disease (COPD). Separate randomized,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of aerosol medicine 2014-12, Vol.27 (6), p.478-487
Hauptverfasser:	Gross, Nicholas, Greos, Leon S, Meltzer, Eli O, Spangenthal, Selwyn, Fishman, Robert S, Spyker, Daniel A, Cassella, James V
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Adolescent Adult Aerosols Aged Albuterol - administration & dosage Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Asthma - diagnosis Asthma - drug therapy Asthma - physiopathology Bronchial Spasm - chemically induced Bronchial Spasm - drug therapy Bronchial Spasm - physiopathology Bronchodilator Agents - administration & dosage Double-Blind Method Female Forced Expiratory Volume Humans Loxapine - administration & dosage Loxapine - adverse effects Lung - drug effects Lung - physiopathology Male Middle Aged Original Research Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - physiopathology Respiratory System Agents - administration & dosage Respiratory System Agents - adverse effects Time Factors Treatment Outcome United States Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!